Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial

This publication has 22 references indexed in Scilit:

• Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa
  Trends in Parasitology, 2003
• Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial
  The Lancet, 2002
• The evolution of drug–resistant malaria: the role of drug elimination half–life
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2002
• Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2002
• Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
  The Lancet, 2001
• Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum
  The Journal of Infectious Diseases, 2000
• The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses
  Parasitology Today, 1997
• Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria
  Antimicrobial Agents and Chemotherapy, 1997
• Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997
• Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993